Is a complete BVMF/LILY34 research report available?

No complete published report is available for bvmf/LILY34 (BVMF/LILY34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bvmf/LILY34 stock profile: metrics, valuation and analysis

Market cap	5.1T
Revenue (ttm)	412.7B
Net income (ttm)	138.4B
EPS (ttm)	R$154
P/E (trailing)	36.9x
P/E (forward)	28.4x
Dividend	R$0.77 (0.40%)
Volume	54,243
Beta	0.51

All BVMF/LILY34 indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	50,000
Employees Change	4,000%
Employees Change Percent	9.3
Enterprise value	BRL 5.3T
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	BRLILYBDR006
Last refreshed	2026-09-12
Market cap	BRL 5.1T
Price	BRL 192
Price currency	BRL
Rev Per Employee	8,254,672.26x
Sector	Healthcare
Sector PE	44.4
Sector PE Fwd	12.1
Sic	2834
Symbol	bvmf/LILY34
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.71%
EV Earnings	38.54x
EV/EBIT	26.41x
EV/EBITDA	24.96x
EV/FCF	56.59x
EV/Sales	13.13x
FCF yield	1.85%
Forward P/E	28.41x
P/B ratio	29.07x
P/E ratio	36.87x
P/S ratio	12.36x
PE Ratio10 Y	52.78x
PE Ratio3 Y	71.41x
PE Ratio5 Y	62.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.72%
EBITDA Margin	52.35%
FCF margin	23.18%
Gross margin	83.4%
Gross Profit	BRL 344.2B
Gross Profit Growth	50.96%
Gross Profit Growth Q	50.31%
Gross Profit Growth3 Y	42.51%
Gross Profit Growth5 Y	26.7%
Net Income	BRL 138.4B
Net Income Growth	93.56%
Net Income Growth Q	25.33%
Net Income Growth Qo Q	-4.07%
Net Income Growth3 Y	60.19%
Net Income Growth5 Y	34.49%
Pretax Margin	42.17%
Profit Margin	33.53%
Profit Per Employee	BRL 2.8M
ROA	20.36
Roa5y	13.51
ROCE	41.89
ROE	102.3
Roe5y	74.21
ROIC	42.24
Roic5y	35.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	38.25%
Cagr1y	41.42%
Cagr3y	25.8%
Cagr5y	36.31%
Div CAGR10	8.48%
Div CAGR3	15.63%
Div CAGR5	15.84%
EPS Growth	94.8
EPS Growth Q	26.23
EPS Growth Qo Q	-3.87
EPS Growth3 Y	60.68
EPS Growth5 Y	34.97
FCF Growth	272.37%
FCF Growth Q	458.06%
FCF Growth Qo Q	157.96%
FCF Growth3 Y	69.77%
FCF Growth5 Y	26.73%
OCF Growth	156.73%
OCF Growth Q	246.29%
OCF Growth Qo Q	100.45%
OCF Growth10 Y	23.94%
OCF Growth3 Y	65.09%
OCF Growth5 Y	31.67%
Revenue Growth	49.58x
Revenue Growth Q	47.67x
Revenue Growth Qo Q	16.04x
Revenue Growth3 Y	39.23x
Revenue Growth5 Y	24.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.66
Assets	BRL 737.1B
Cash	BRL 46.4B
Current Assets	BRL 330.1B
Current Liabilities	BRL 243.7B
Debt	BRL 284.5B
Debt EBITDA	BRL 1.31
Debt Equity	BRL 1.62
Debt FCF	BRL 3.02
Equity	BRL 175.5B
Interest Coverage	215.3
Liabilities	BRL 561.6B
Long Term Assets	BRL 407B
Long Term Liabilities	BRL 317.9B
Net Cash	BRL -234B
Net Cash By Market Cap	BRL -4.59
Net Debt EBITDA	BRL 1.08
Net Debt Equity	BRL 1.33
Net Debt FCF	BRL 2.48
Tangible Book Value	BRL 35.9B
Tangible Book Value Per Share	BRL 40.21
WACC	6.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.35
Inventory Turnover	0.95
Net Working Capital	BRL 77.9B
Quick ratio	0.68
Working Capital	BRL 87.7B
Working Capital Turnover	BRL 29.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend Growth	16.05%
Dividend Growth Years	6%
Dividend per share	BRL 0.77
Dividend Years	15
Dividend Yield	0.4%
Ex Div Date	2026-08-13
Last Dividend	BRL 0.04
Payout Frequency	Quarterly
Payout Ratio	21.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	2,449.26%
1Y total return	41.39%
200-day SMA	184.6
3Y total return	99.13%
50-day SMA	203.3
50-day SMA vs 200-day SMA	50over200
5Y total return	370.43%
All Time High	223.1
All Time High Change	-14.11%
All Time High Date	2026-08-19
All Time Low	2.96
All Time Low Change	6,383.93%
All Time Low Date	2012-08-24
ATR	6.28
Beta	0.51
Ch YTD	-2.89
High	195.6
High52	223.1
High52 Date	2026-08-19
High52ch	-14.11%
Low	191.1
Low52	126.7
Low52 Date	2025-09-29
Low52ch	51.2%
Ma50ch	-5.77%
Price vs 200-day SMA	3.81%
RSI	36.62
RSI Monthly	58.71
RSI Weekly	50.85
Sharpe ratio	1.12x
Sharpe Ratio3y	0.76x
Sharpe Ratio5y	0.86x
Sortino ratio	2.03
Sortino Ratio3y	1.29
Sortino Ratio5y	1.48
Total Return	1.02%
Tr YTD	-2.57
Tr1m	-5.1%
Tr1w	-3.13%
Tr3m	-3.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	888,950,429%
Net Borrowing	77,665,507,200
Shares Insiders	0.17%
Shares Institutions	89.5%
Shares Qo Q	-0.25%
Shares Yo Y	-0.62%
Short Ratio	2.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 90.9B
Adjusted OCF	142,130,067,200
Average Volume	54,732.35x
Bv Per Share	196.9
CAPEX	BRL -51.3B
Ch10y	2,155.2
Ch1m	-5.19
Ch1w	-3.13
Ch1y	40.78
Ch3m	-3.31
Ch3y	96.31
Ch5y	356.2
Ch6m	11.23
Change	-0.01%
Change From Open	-0.77
Close	191.6
Days Gap	0.77
Depreciation Amortization	10,713,715,800
Dollar Volume	10,392,959.3
Earnings Date	2026-10-29
EBIT	BRL 205.2B
EBITDA	BRL 216.1B
EPS	BRL 154
F Score	7
FCF	BRL 94.2B
FCF EV Yield	1.77x
Financing CF	13,511,526,400
Fiscal Year End	December
Founded	1,876
Goodwill	45,167,065,800
Graham Number	27.75964
Graham Upside	-85.51
Income Tax	BRL 35.7B
Investing CF	-130,022,537,600
Is Primary Listing	0
Last Earnings Date	2026-08-05
Last Report Date	2026-06-30
Last Split Date	2022-11-21
Last Split Type	Forward
Lynch Fair Value	BRL 130
Lynch Upside	-32.2
Ma150	183
Ma150ch	4.7%
Ma20	204.7
Ma20ch	-6.41%
Net CF	28,877,779,200
Next Earnings Date	2026-10-29
Open	193.1
P FCF Ratio	54.14
P FCF Ratio SBC	56.15
P OCF Ratio	35.07
P OCF Ratio SBC	35.9
Payment Date	2026-09-16
Position In Range	11.97
Ppne	149,481,601,200
Price Date	2026-09-10
Price EBITDA	BRL 23.61
Ptbv Ratio	142.3
Relative Volume	0.96x
Revenue	412,733,612,800x
SBC By Revenue	0.81x
Share Based Comp	3,362,339,200
Tax By Revenue	8.64x
Tax Rate	20.49%
Tr6m	11.46%
Volume	54,243
Z Score	6.55

BVMF/LILY34 (BVMF/LILY34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/LILY34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/LILY34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BVMF/LILY34

Frequently asked questions